Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy

Journal of Neuro-Oncology

Volumn 119, Issue 3, 2014, Pages 513-529

  Ding, Dale ^a   Yen, Chun Po ^a   Starke, Robert M ^a   Lee, Cheng Chia ^a   Sheehan, Jason P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Brain neoplasms; Neoplasm metastasis; Pituitary neoplasms; Radiosurgery; Radiotherapy

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID;

ACOUSTIC NEURINOMA; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CRANIAL NEUROPATHY; CYBERKNIFE; EXTERNAL BEAM RADIOTHERAPY; GAMMA KNIFE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; LINEAR ACCELERATOR; LONG TERM SURVIVAL; MENINGIOMA; NEUROSURGERY; NONFUNCTIONING PITUITARY ADENOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROLACTINOMA; PROTON THERAPY; RADIATION INDUCED NEOPLASM; RADIATION NECROSIS; RADIOSURGERY; REVIEW; SALVAGE THERAPY; SECOND CANCER; SPINAL CORD TUMOR; STEREOTACTIC RADIOSURGERY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; WHOLE BRAIN RADIATION THERAPY; BRAIN NEOPLASMS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BRAIN NEOPLASMS; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84919454892     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1501-7     Document Type: Review

References (137)

1. Seymour ZA, Cohen-Gadol AA (2010) Cushing’s lost cases of “radium bomb” brachytherapy for gliomas. J Neurosurg 113(1):141–148. doi:10.3171/2009.11.JNS091393
2. Clarke RH, Horsley V (2007) THE CLASSIC: on a method of investigating the deep ganglia and tracts of the central nervous system (cerebellum). Br Med J 1906:1799–1800. Clin Orthop Relat Res 463:3–6. doi:10.1097/BLO.0b013e31814d4d99
3. Spiegel EA, Wycis HT, Marks M, Lee AJ (1947) Stereotaxic apparatus for operations on the human brain. Science 106(2754):349–350. doi:10.1126/science.106.2754.349
4. Leksell L (1951) The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102(4):316–319
5. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622):1155–1159. doi:10.1126/science.1082504
6. Seung SK, Larson DA, Galvin JM, Mehta MP, Potters L, Schultz CJ, Yajnik SV, Hartford AC, Rosenthal SA (2006) American college of radiology (ACR) and american society for radiation oncology (ASTRO) practice guideline for the performance of stereotactic radiosurgery (SRS). Am J Clin Oncol 36(3):310–315. doi:10.1097/COC.0b013e31826e053d
7. Barnett GH, Linskey ME, Adler JR, Cozzens JW, Friedman WA, Heilbrun MP, Lunsford LD, Schulder M, Sloan AE (2007) Stereotactic radiosurgery—an organized neurosurgery-sanctioned definition. J Neurosurg 106(1):1–5. doi:10.3171/jns.2007.106.1.1
8. Schlesinger D, Xu Z, Taylor F, Yen CP, Sheehan J (2012) Interfraction and intrafraction performance of the gamma knife extend system for patient positioning and immobilization. J Neurosurg 117(Suppl):217–224. doi:10.3171/2012.6.GKS12989
9. Sayer FT, Sherman JH, Yen CP, Schlesinger DJ, Kersh R, Sheehan JP (2011) Initial experience with the eXtend System: a relocatable frame system for multiple-session gamma knife radiosurgery. World Neurosurg 75(5–6):665–672. doi:10.1016/j.wneu.2010.12.051
10. Hoybye C, Rahn T (2009) Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients. Pituitary 12(3):211–216. doi:10.1007/s11102-008-0163-x
11. Losa M, Valle M, Mortini P, Franzin A, da Passano CF, Cenzato M, Bianchi S, Picozzi P, Giovanelli M (2004) Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100(3):438–444. doi:10.3171/jns.2004.100.3.0438
12. Muacevic A, Uhl E, Wowra B (2004) Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir (Suppl) 91:51–54
13. Iwai Y, Yamanaka K, Yoshioka K (2005) Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery 56(4):699–705 (discussion 699–705)
14. Kajiwara K, Saito K, Yoshikawa K, Kato S, Akimura T, Nomura S, Ishihara H, Suzuki M (2005) Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg 48(2):91–96. doi:10.1055/s-2004-830261
15. Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, Ferrari da Passano C, Giovanelli M (2005) Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg 102(Suppl):71–74
16. Mingione V, Yen CP, Vance ML, Steiner M, Sheehan J, Laws ER, Steiner L (2006) Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg 104(6):876–883. doi:10.3171/jns.2006.104.6.876
17. Voges J, Kocher M, Runge M, Poggenborg J, Lehrke R, Lenartz D, Maarouf M, Gouni-Berthold I, Krone W, Muller RP, Sturm V (2006) Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107(6):1355–1364. doi:10.1002/cncr.22128
18. Liscak R, Vladyka V, Marek J, Simonova G, Vymazal J (2007) Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir (Wien) 149(10):999–1006. doi:10.1007/s00701-007-1253-7 (discussion 1006)
19. Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, Garces YI, Foote RL, Stafford SL, Schomberg PJ (2008) Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 70(5):1325–1329. doi:10.1016/j.ijrobp.2007.08.018
20. Kobayashi T (2009) Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma. Prog Neurol Surg 22:77–95. doi:10.1159/000163384
21. Castro DG, Cecilio SA, Canteras MM (2010) Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety. Radiat Oncol 5:109. doi:10.1186/1748-717X-5-109
22. Hayashi M, Chernov M, Tamura N, Nagai M, Yomo S, Ochiai T, Amano K, Izawa M, Hori T, Muragaki Y, Iseki H, Okada Y, Takakura K (2010) Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases. J Neurooncol 98(2):185–194. doi:10.1007/s11060-010-0172-2
23. Gopalan R, Schlesinger D, Vance ML, Laws E, Sheehan J (2011) Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery 69(2):284–293. doi:10.1227/NEU.0b013e31821bc44e
24. Iwata H, Sato K, Tatewaki K, Yokota N, Inoue M, Baba Y, Shibamoto Y (2011) Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro Oncol 13(8):916–922. doi:10.1093/neuonc/nor055
25. Park KJ, Kano H, Parry PV, Niranjan A, Flickinger JC, Lunsford LD, Kondziolka D (2011) Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery 69(6):1188–1199. doi:10.1227/NEU.0b013e318222afed
26. El-Shehaby AM, Reda WA, Tawadros SR, Abdel Karim KM (2012) Low-dose Gamma Knife surgery for nonfunctioning pituitary adenomas. J Neurosurg 117(Suppl):84–88. doi:10.3171/2012.6.GKS12986
27. Runge MJ, Maarouf M, Hunsche S, Kocher M, Ruge MI, El Majdoub F, Treuer H, Mueller RP, Voges J, Sturm V (2012) LINAC-radiosurgery for nonsecreting pituitary adenomas. Long-term results. Strahlenther Onkol 188(4):319–325. doi:10.1007/s00066-011-0052-5
28. Starke RM, Williams BJ, Jane JA Jr, Sheehan JP (2012) Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg 117(1):129–135. doi:10.3171/2012.4.JNS112250
29. Wilson PJ, De-Loyde KJ, Williams JR, Smee RI (2012) A single centre’s experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the Linear Accelerator (Linac). J Clin Neurosci 19(3):370–374. doi:10.1016/j.jocn.2011.07.025
30. Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL, Lee JY, Kano H, Park KJ, Niranjan A, Kondziolka D, Barnett GH, Rush S, Golfinos JG, Lunsford LD (2013) Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg 119(2):446–456. doi:10.3171/2013.3.JNS12766
31. Devin JK, Allen GS, Cmelak AJ, Duggan DM, Blevins LS (2004) The efficacy of linear accelerator radiosurgery in the management of patients with Cushing’s disease. Stereotact Funct Neurosurg 82(5–6):254–262. doi:10.1159/000083476
32. Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Regis J, Dufour H, Brue T (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90(8):4483–4488. doi:10.1210/jc.2005-0311
33. Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, Schopohl J (2005) Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes 113(4):219–224. doi:10.1055/s-2005-837552
34. Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani S (2005) Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure? J Neurosurg 102(Suppl):119–123
35. Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, Lisak R, Vymazal J, Pecen L (2006) Gamma knife radiosurgery for acromegaly–long-term experience. Clin Endocrinol (Oxf) 64(5):588–595. doi:10.1111/j.1365-2265.2006.02513.x
36. Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59(2):255–266. doi:10.1227/01.NEU.0000223445.22938.BD (discussion 255–266)
37. Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, Conte-Devolx B, Regis J, Brue T (2007) Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease. Eur J Endocrinol 156(1):91–98. doi:10.1530/eje.1.02323
38. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML (2007) Gamma Knife surgery for Cushing’s disease. J Neurosurg 106(6):980–987. doi:10.3171/jns.2007.106.6.980
39. Pollock BE, Jacob JT, Brown PD, Nippoldt TB (2007) Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106(5):833–838. doi:10.3171/jns.2007.106.5.833
40. Roberts BK, Ouyang DL, Lad SP, Chang SD, Harsh GRt, Adler JR Jr, Soltys SG, Gibbs IC IC, Katznelson L (2007) Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 10(1):19–25. doi:10.1007/s11102-007-0004-3
41. Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rodahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2007) Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol 157(3):255–263. doi:10.1530/EJE-07-0189
42. Jagannathan J, Sheehan JP, Pouratian N, Laws ER Jr, Steiner L, Vance ML (2008) Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 62(6):1262–1269. doi:10.1227/01.neu.0000333297.41813.3d (discussion 1269–1270)
43. Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, Mortini P (2008) The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93(7):2546–2552. doi:10.1210/jc.2008-0135
44. Petit JH, Biller BM, Yock TI, Swearingen B, Coen JJ, Chapman P, Ancukiewicz M, Bussiere M, Klibanski A, Loeffler JS (2008) Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 93(2):393–399. doi:10.1210/jc.2007-1220
45. Pollock BE, Brown PD, Nippoldt TB, Young WF Jr (2008) Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery 62(6):1271–1276. doi:10.1227/01.neu.0000333298.49436.0e (discussion 1276–1278)
46. Tinnel BA, Henderson MA, Witt TC, Fakiris AJ, Worth RM, Des Rosiers PM, Edmondson JW, Timmerman RD, Lo SS (2008) Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma. Stereotact Funct Neurosurg 86(5):292–296. doi:10.1159/000151717
47. Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Regis J, Brue T (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94(9):3400–3407. doi:10.1210/jc.2008-2772
48. Jezkova J, Hana V, Krsek M, Weiss V, Vladyka V, Liscak R, Vymazal J, Pecen L, Marek J (2009) Use of the Leksell gamma knife in the treatment of prolactinoma patients. Clin Endocrinol (Oxf) 70(5):732–741. doi:10.1111/j.1365-2265.2008.03384.x
49. Ronchi CL, Attanasio R, Verrua E, Cozzi R, Ferrante E, Loli P, Montefusco L, Motti E, Ferrari DI, Giugni E, Beck-Peccoz P, Arosio M (2009) Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study. Clin Endocrinol (Oxf) 71(6):846–852. doi:10.1111/j.1365-2265.2009.03589.x
50. Wan H, Chihiro O, Yuan S (2009) MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases. J Exp Clin Cancer Res 28:36. doi:10.1186/1756-9966-28-36
51. Iwai Y, Yamanaka K, Yoshimura M, Kawasaki I, Yamagami K, Yoshioka K (2010) Gamma knife radiosurgery for growth hormone-producing adenomas. J Clin Neurosci 17(3):299–304. doi:10.1016/j.jocn.2009.05.040
52. Poon TL, Leung SC, Poon CY, Yu CP (2010) Predictors of outcome following Gamma Knife surgery for acromegaly. J Neurosurg 113(Suppl):149–152
53. Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF Jr, Pollock BE (2010) Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 74(1):147–152. doi:10.1016/j.wneu.2010.05.007
54. Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML (2011) Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114(2):303–309. doi:10.3171/2010.5.JNS091635
55. Franzin A, Spatola G, Losa M, Picozzi P, Mortini P (2012) Results of gamma knife radiosurgery in acromegaly. Int J Endocrinol 2012:342034. doi:10.1155/2012/342034
56. Liu X, Kano H, Kondziolka D, Park KJ, Iyer A, Niranjan A, Flickinger JC, Lunsford LD (2012) Gamma knife radiosurgery for clinically persistent acromegaly. J Neurooncol 109(1):71–79. doi:10.1007/s11060-012-0862-z
57. Wein L, Dally M, Bach LA (2012) Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience. Intern Med J 42(10):1153–1156. doi:10.1111/j.1445-5994.2012.02903.x
58. Grant RA, Whicker M, Lleva R, Knisely JP, Inzucchi SE, Chiang VL (2013) Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report. World Neurosurg. doi:10.1016/j.wneu.2013.01.127
59. Sheehan JP, Xu Z, Salvetti DJ, Schmitt PJ, Vance ML (2013) Results of Gamma Knife surgery for Cushing’s disease. J Neurosurg 119(6):1486–1492. doi:10.3171/2013.7.JNS13217
60. Wilson PJ, De-Loyde KJ, Williams JR, Smee RI (2013) Acromegaly: a single centre’s experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator. J Clin Neurosci 20(11):1506–1513. doi:10.1016/j.jocn.2012.11.026
61. Yan JL, Chang CN, Chuang CC, Hsu PW, Lin JD, Wei KC, Lee ST, Tseng JK, Pai PC, Chen YL (2013) Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery. J Formos Med Assoc 112(7):416–420. doi:10.1016/j.jfma.2012.01.020
62. Wilson PJ, Williams JR, Smee RI (2014) Cushing’s disease: a single centre’s experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy. J Clin Neurosci 21(1):100–106. doi:10.1016/j.jocn.2013.04.007
63. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (2000) Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85(3):1287–1289
64. Liu X, Kano H, Kondziolka D, Park KJ, Iyer A, Shin S, Niranjan A, Flickinger JC, Lunsford LD (2013) Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas. Pituitary 16(1):68–75. doi:10.1007/s11102-012-0376-x
65. Ding D, Starke RM, Sheehan JP (2013) Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy. J Neurooncol. doi:10.1007/s11060-013-1262-8
66. Pollock BE, Nippoldt TB, Stafford SL, Foote RL, Abboud CF (2002) Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 97(3):525–530. doi:10.3171/jns.2002.97.3.0525
67. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M (2003) Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88(7):3105–3112
68. Landolt AM, Lomax N (2000) Gamma knife radiosurgery for prolactinomas. J Neurosurg 93(Suppl 3):14–18. doi:10.3171/jns.2000.93.supplement3.0014
69. Lim YJ, Leem W, Park JT, Kim TS, Rhee BA, Kim GK (1999) Cerebral infarction with ICA occlusion after Gamma Knife radiosurgery for pituitary adenoma: a case report. Stereotact Funct Neurosurg 72(Suppl 1):132–139
70. Loeffler JS, Niemierko A, Chapman PH (2003) Second tumors after radiosurgery: tip of the iceberg or a bump in the road? Neurosurgery 52(6):1436–1440 (discussion 1440–1432)
71. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33(2):307–314. doi:10.1016/0360-3016(95)00071-6
72. Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, Muller RP, Bamberg M (2002) Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178(4):173–186
73. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122
74. Brada M, Burchell L, Ashley S, Traish D (1999) The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 45(3):693–698
75. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88(6):1002–1008. doi:10.3171/jns.1998.88.6.1002
76. Liu JK, Schmidt MH, MacDonald JD, Jensen RL, Couldwell WT (2003) Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note. Neurosurg Focus 14(5):e11
77. Taussky P, Kalra R, Coppens J, Mohebali J, Jensen R, Couldwell WT (2011) Endocrinological outcome after pituitary transposition (hypophysopexy) and adjuvant radiotherapy for tumors involving the cavernous sinus. J Neurosurg 115(1):55–62. doi:10.3171/2011.2.JNS10566
78. Stucken EZ, Brown K, Selesnick SH (2012) Clinical and diagnostic evaluation of acoustic neuromas. Otolaryngol Clin North Am 45(2):269–284, vii. doi:10.1016/j.otc.2011.12.001
79. Lau T, Olivera R, Miller T Jr, Downes K, Danner C, van Loveren HR, Agazzi S (2012) Paradoxical trends in the management of vestibular schwannoma in the United States. J Neurosurg 117(3):514–519. doi:10.3171/2012.5.JNS111858
80. Chopra R, Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC (2007) Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 68(3):845–851. doi:10.1016/j.ijrobp.2007.01.001
81. Hasegawa T, Kida Y, Kato T, Iizuka H, Kuramitsu S, Yamamoto T (2013) Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery. J Neurosurg 118(3):557–565. doi:10.3171/2012.10.JNS12523
82. Baschnagel AM, Chen PY, Bojrab D, Pieper D, Kartush J, Didyuk O, Naumann IC, Maitz A, Grills IS (2013) Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery. J Neurosurg 118(3):571–578. doi:10.3171/2012.10.JNS12880
83. Carlson ML, Jacob JT, Pollock BE, Neff BA, Tombers NM, Driscoll CL, Link MJ (2013) Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg 118(3):579–587. doi:10.3171/2012.9.JNS12919
84. Friedman WA, Bradshaw P, Myers A, Bova FJ (2006) Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg 105(5):657–661. doi:10.3171/jns.2006.105.5.657
85. Tamura M, Carron R, Yomo S, Arkha Y, Muraciolle X, Porcheron D, Thomassin JM, Roche PH, Regis J (2009) Hearing preservation after gamma knife radiosurgery for vestibular schwannomas presenting with high-level hearing. Neurosurgery 64(2):289–296. doi:10.1227/01.NEU.0000338256.87936.7C (discussion 296)
86. Massager N, Nissim O, Delbrouck C, Delpierre I, Devriendt D, Desmedt F, Wikler D, Brotchi J, Levivier M (2007) Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg 107(4):733–739. doi:10.3171/JNS-07/10/0733
87. Delbrouck C, Hassid S, Massager N, Choufani G, David P, Devriendt D, Levivier M (2003) Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study. Acta Otorhinolaryngol Belg 57(3):197–204
88. Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD, Mandrekar JN, Krecke KN, Johnson CH (2006) Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59(1):77–85. doi:10.1227/01.NEU.0000219217.14930.14 (discussion 77-85)
89. Wolbers JG, Dallenga AH, Mendez Romero A, van Linge A (2013) What intervention is best practice for vestibular schwannomas? A systematic review of controlled studies. BMJ Open 3(2). doi:10.1136/bmjopen-2012-001345
90. Ansari SF, Terry C, Cohen-Gadol AA (2012) Surgery for vestibular schwannomas: a systematic review of complications by approach. Neurosurg Focus 33(3):E14. doi:10.3171/2012.6.FOCUS12163
91. van de Langenberg R, Hanssens PE, van Overbeeke JJ, Verheul JB, Nelemans PJ, de Bondt BJ, Stokroos RJ (2011) Management of large vestibular schwannoma. Part I. Planned subtotal resection followed by Gamma Knife surgery: radiological and clinical aspects. J Neurosurg 115(5):875–884. doi:10.3171/2011.6.JNS101958
92. Samii M, Gerganov VM, Samii A (2010) Functional outcome after complete surgical removal of giant vestibular schwannomas. J Neurosurg 112(4):860–867. doi:10.3171/2009.7.JNS0989
93. Pan HC, Sheehan J, Sheu ML, Chiu WT, Yang DY (2012) Intracapsular decompression or radical resection followed by Gamma Knife surgery for patients harboring a large vestibular schwannoma. J Neurosurg 117(Suppl):69–77. doi:10.3171/2012.6.GKS12697
94. Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J (2010) Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 76(1):193–200. doi:10.1016/j.ijrobp.2009.01.064
95. Kondziolka D, Mathieu D, Lunsford LD, Martin JJ, Madhok R, Niranjan A, Flickinger JC (2008) Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 62(1):53–58. doi:10.1227/01.NEU.0000311061.72626.0D (discussion 58–60)
96. Starke R, Kano H, Ding D, Nakaji P, Barnett GH, Mathieu D, Chiang V, Yu JB, Hess J, McBride HL, Honea N, Lee JY, Rahmathulla G, Evanoff WA, Alonso-Basanta M, Lunsford LD, Sheehan JP (2014) Stereotactic radiosurgery of petroclival meningiomas: a multicenter study. J Neurooncol. doi:10.1007/s11060-014-1470-x
97. Ding D, Starke RM, Hantzmon J, Yen CP, Williams BJ, Sheehan JP (2013) The role of radiosurgery in the management of WHO Grade II and III intracranial meningiomas. Neurosurg Focus 35(6):E16. doi:10.3171/2013.9.FOCUS13364
98. Sheehan JP, Williams BJ, Yen CP (2010) Stereotactic radiosurgery for WHO grade I meningiomas. J Neurooncol 99(3):407–416. doi:10.1007/s11060-010-0363-x
99. Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA (2003) Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 55(4):1000–1005
100. Starke RM, Williams BJ, Hiles C, Nguyen JH, Elsharkawy MY, Sheehan JP (2012) Gamma knife surgery for skull base meningiomas. J Neurosurg 116(3):588–597. doi:10.3171/2011.11.JNS11530
101. Combs SE, Ganswindt U, Foote RL, Kondziolka D, Tonn JC (2012) State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques. Radiat Oncol 7:226. doi:10.1186/1748-717X-7-226
102. Combs SE, Adeberg S, Dittmar JO, Welzel T, Rieken S, Habermehl D, Huber PE, Debus J (2013) Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol 106(2):186–191. doi:10.1016/j.radonc.2012.07.008
103. Chang JH, Chang JW, Choi JY, Park YG, Chung SS (2003) Complications after gamma knife radiosurgery for benign meningiomas. J Neurol Neurosurg Psychiatry 74(2):226–230
104. Ding D, Xu Z, McNeill IT, Yen CP, Sheehan JP (2013) Radiosurgery for parasagittal and parafalcine meningiomas. J Neurosurg 119(4):871–877. doi:10.3171/2013.6.JNS13110
105. Sughrue ME, Rutkowski MJ, Chen CJ, Shangari G, Kane AJ, Parsa AT, Berger MS, McDermott MW (2013) Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg 119(1):86–93. doi:10.3171/2012.12.JNS11539
106. Nanda A, Javalkar V, Banerjee AD (2011) Petroclival meningiomas: study on outcomes, complications and recurrence rates. J Neurosurg 114(5):1268–1277. doi:10.3171/2010.11.JNS10326
107. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672. doi:10.1016/S0140-6736(04)16250-8
108. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483–2491. doi:10.1001/jama.295.21.2483
109. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87(3):299–307. doi:10.1007/s11060-007-9510-4
110. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044. doi:10.1016/S1470-2045(09)70263-3
111. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29(2):134–141. doi:10.1200/JCO.2010.30.1655
112. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5):1388–1395. doi:10.1016/j.ijrobp.2007.03.048
113. Lal LS, Byfield SD, Chang EL, Franzini L, Miller LA, Arbuckle R, Reasonda L, Feng C, Adamus A, Swint JM (2012) Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases. Am J Clin Oncol 35(1):45–50. doi:10.1097/COC.0b013e3182005a8f
114. Tsao M, Xu W, Sahgal A (2013) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486–2493. doi:10.1002/cncr.26515
115. Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M, Shaw P, Beyene J, Chang EL (2013) Individual Patient Data (IPD) Meta-analysis of randomized controlled trials (RCT) comparing stereotactic radiosurgery alone to SRS plus whole brain radiation therapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 87(5):1187. doi:10.1016/j.ijrobp.2013.10.007
116. Serizawa T, Yamamoto M, Sato Y, Higuchi Y, Nagano O, Kawabe T, Matsuda S, Ono J, Saeki N, Hatano M, Hirai T (2010) Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg 113(Suppl):48–52
117. Grandhi R, Kondziolka D, Panczykowski D, Monaco EA 3rd, Kano H, Niranjan A, Flickinger JC, Lunsford LD (2012) Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. J Neurosurg 117(2):237–245. doi:10.3171/2012.4.JNS11870
118. Salvetti DJ, Nagaraja TG, McNeill IT, Xu Z, Sheehan J (2013) Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article. J Neurosurg 118(6):1250–1257. doi:10.3171/2013.2.JNS121213
119. Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Barfod BE, Kasuya H, Urakawa Y (2013) A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1–4 vs >/= 5 tumors: clinical article. J Neurosurg 118(6):1258–1268. doi:10.3171/2013.3.JNS121900
120. Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, Fuhrer R (2009) Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 27(6):E7. doi:10.3171/2009.9.FOCUS09191
121. Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, Chan TA, Lymberis SC, Narayana A, Tabar V, Gutin PH, Ballangrud A, Lis E, Beal K (2014) A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys 88(1):130–136. doi:10.1016/j.ijrobp.2013.09.051
122. Cahan WG, Woodard HQ et al (1948) Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1(1):3–29
123. Starke RM, Yen CP, Chen CJ, Ding D, Mohila CA, Jensen ME, Kassell NF, Sheehan JP (2013) An updated assessment of the risk of radiation-induced neoplasia after radiosurgery of arteriovenous malformations. World Neurosurg. doi:10.1016/j.wneu.2013.02.008
124. Patel TR, Chiang VL (2014) Secondary neoplasms after stereotactic radiosurgery. World Neurosurg 81(3–4):594–599. doi:10.1016/j.wneu.2013.10.043
125. Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A (2007) Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60(1):60–65. doi:10.1227/01.NEU.0000255492.34063.32 (discussion 65–66)
126. Nath SK, Sheridan AD, Rauch PJ, Yu JB, Minja FJ, Vortmeyer AO, Chiang VL (2014) Significance of histology in determining management of lesions regrowing after radiosurgery. J Neurooncol 117(2):303–310. doi:10.1007/s11060-014-1389-2
127. Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66(3):486–491. doi:10.1227/01.NEU.0000360391.35749.A5 (discussion 491-482)
128. Shah AH, Snelling B, Bregy A, Patel PR, Tememe D, Bhatia R, Sklar E, Komotar RJ (2013) Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality? J Neurooncol 112(2):141–152. doi:10.1007/s11060-013-1059-9
129. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79(5):1487–1495. doi:10.1016/j.ijrobp.2009.12.061
130. Deibert CP, Ahluwalia MS, Sheehan JP, Link MJ, Hasegawa T, Yomo S, Feng WH, Li P, Flickinger JC, Lunsford LD, Kondziolka D (2013) Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol 115(2):217–223. doi:10.1007/s11060-013-1214-3
131. Rahmathulla G, Recinos PF, Valerio JE, Chao S, Barnett GH (2012) Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 90(3):192–200. doi:10.1159/000338251
132. Hamilton AJ, Lulu BA, Fosmire H, Gossett L (1996) LINAC-based spinal stereotactic radiosurgery. Stereotact Funct Neurosurg 66(1–3):1–9
133. Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32(2):193–199. doi:10.1097/01.brs.0000251863.76595.a2
134. Sachdev S, Dodd RL, Chang SD, Soltys SG, Adler JR, Luxton G, Choi CY, Tupper L, Gibbs IC (2011) Stereotactic radiosurgery yields long-term control for benign intradural, extramedullary spinal tumors. Neurosurgery 69(3):533–539. doi:10.1227/NEU.0b013e318218db23 (discussion 539)
135. Adler JR Jr, Gibbs IC, Puataweepong P, Chang SD (2008) Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 62(Suppl 2):733–743. doi:10.1227/01.neu.0000316277.14748.63
136. Mack A, Wolff R, Scheib S, Rieker M, Weltz D, Mack G, Kreiner HJ, Pilatus U, Zanella FE, Bottcher HD, Seifert V (2005) Analyzing 3-tesla magnetic resonance imaging units for implementation in radiosurgery. J Neurosurg 102(Suppl):158–164
137. Koga T, Shin M, Maruyama K, Kamada K, Ota T, Itoh D, Kunii N, Ino K, Aoki S, Masutani Y, Igaki H, Onoe T, Saito N (2012) Integration of corticospinal tractography reduces motor complications after radiosurgery. Int J Radiat Oncol Biol Phys 83(1):129–133. doi:10.1016/j.ijrobp.2011.05.036